We are live on ! Find out more
MLAB icon

Mesa Laboratories

69 hedge funds and large institutions have $218M invested in Mesa Laboratories in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 20

6% more funds holding

Funds holding: 6569 (+4)

8% less capital invested

Capital invested by funds: $238M → $218M (-$19.2M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
69
Holders Change
+4
Holders Change %
+6.15%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
6
Increased
30
Reduced
20
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MLAB Hedge Fund Activity: Q4 2015 in Review

69 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2015, worth a combined $218M — down 8.1% from $238M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MLAB positions and 2 closed out — a net gain of 4 holders — while 30 added to existing stakes and 20 trimmed.

The largest buyer was LPL Financial, adding an estimated $5.24M. The largest seller was Freedom Investment Management, cutting an estimated $1.96M.

  • 69 institutional investors held Mesa Laboratories (MLAB) as of Q4 2015, up from 65 in Q3 2015.
  • Funds reported $218M of Mesa Laboratories stock for Q4 2015, down 8.1% quarter-over-quarter.
  • 6 funds opened new Mesa Laboratories positions in Q4 2015 and 2 closed out, a net change of +4 holders.
  • The largest Mesa Laboratories buyer in Q4 2015 was LPL Financial, an estimated $5.24M added.
  • The largest Mesa Laboratories seller in Q4 2015 was Freedom Investment Management, an estimated $1.96M sold.

Based on aggregated 13F filings for Q4 2015.